Tag: show

>>

Lorlatinib Follow-up Data Show Prolonged Progression-Free Survival in ALK-Positive Advanced Lung Cancer

Pfizer today announced long-term follow-up results from the CROWN study7.8Phase III trial evaluating lorlatinib (▼Lorviqua®),…

Waiting lists show a historic hole in mental health in Vigo

A patient walks through the old Rebulln hospital Oscar Vázquez Vigo has more patients than…

★ Five-year follow-up data for lorlatinib show prolonged progression-free survival in ALK-positive advanced lung cancer

Pfizer today announced long-term follow-up results from the CROWN study7.8Phase III trial evaluating lorlatinib (▼Lorviqua®),…

Skin cancer can show up in unexpected places

If you've ever had your skin examined by a dermatologist, you know the drill: Prepare…